- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00182299
An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SIS
A Randomized Clinical Trial Comparing the Effectiveness of Rotator Cuff Repair With or Without Augmentation With Porcine Small Intestine Submucosa (SIS) for Large Rotator Cuff Tears: Pilot Study Phase
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective of the full randomized trial To compare the effectiveness of a standardized method of rotator cuff repair with or without augmentation using porcine small intestine submucosa (SIS) in patients with large rotator cuff tears.
Objectives of the pilot study
- To obtain a preliminary estimate of the likely success of SIS.
- To formally evaluate our ability to successfully recruit eligible patients into this study.
- To determine appropriate length of follow up through examination of the pattern of incremental improvement and stabilization of quality of life over time following rotator cuff repair.
- To determine a more accurate estimation of sample size for the full trial using quality of life.
- To determine the frequency with which surgeons comply with the surgical protocol.
- To determine the frequency with which patients and physiotherapists comply with the suggested physiotherapy protocol.
Study Type
Enrollment
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6G 1H1
- The University of Western Ontario
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients with large rotator cuff tears (Type 1B or Type 2) determined by clinical examination and diagnostic imaging. Criteria described by Harryman et al (1991) will guide the classification of rotator cuff tears defined and reassessed at the time of surgery (Type 0 = intact cuff, Type 1A = thinned cuff or partial thickness defect, Type 1B= full thickness defect on one tendon, Type 2 = full thickness defect of two tendons, Type 3 = full thickness defect of three tendons).
Exclusion Criteria:
- Previous shoulder surgery, excluding acromioplasty or diagnostic arthroscopy.
- Inability of the surgeon to repair the tear with remaining defect no greater than 10mm in diameter,
- Inability of the surgeon to repair the tear with less than 1cm of medialization,
- Evidence of other significant shoulder pathology including, Type II-IV SLAP lesion, Bankart lesion, Hill Sachs lesion, Grade III osteoarthritis).
- Active joint or systemic infection,
- Significant muscle paralysis of the shoulder girdle,
- Major medical illness that would preclude undergoing surgery,
- Patients who are unwilling or unable to be assessed according to study protocol for one year following surgery
- Major psychiatric illness, developmental handicap or inability to read and understand the English language
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
MRI defined failure of the cuff repair at 2 years postoperative
|
Secondary Outcome Measures
Outcome Measure |
---|
Quality of life (WORC, ASES), function (SST, CONSTANT), general health (SF-36), pain (VAS), analgesic use; forward flexion; internal/external rotation; lateral elevation
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Dianne M Bryant, PhD, Western University, Canada
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 63140-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Tear
-
Bezmialem Vakif UniversityNot yet recruitingRotator Cuff Tears | Partial Tear of Rotator CuffTurkey
-
Keele UniversityUniversity Hospitals, Leicester; Liverpool University Hospitals NHS Foundation... and other collaboratorsWithdrawnTraumatic Rotator Cuff TearUnited Kingdom
-
Rush University Medical CenterSmith & Nephew, Inc.CompletedRotator Cuff Tear Repair Anchors
-
University of MichiganCompletedFull Thickness Rotator Cuff Tear
-
Johannes Kepler University of LinzCompletedFull Thickness Rotator Cuff TearAustria
-
Lawson Health Research InstituteCompleted
-
Orthofix Inc.TerminatedPEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears (RCStim)Full-thickness Rotator Cuff TearUnited States
-
InGeneron, Inc.CompletedRotator Cuff Tear - Partial ThicknessUnited States
-
Izmir Katip Celebi UniversityTerminatedPartial Thickness Rotator Cuff TearTurkey
-
BioMimetic TherapeuticsCompletedFull Thickness Rotator Cuff TearCanada
Clinical Trials on porcine small intestine submucosa (SIS)
-
Ascension South East MichiganWithdrawnOtologic DiseaseUnited States
-
Cook Group IncorporatedCompletedIschemia | Peripheral Arterial Disease | Peripheral Vascular DiseasesCanada
-
University of CalgaryCorMatrix Cardiovascular, Inc.CompletedHeart Failure | Acute Coronary SyndromeCanada
-
Xiaoyong ZengEnrolling by invitationUrethral Stricture, MaleChina
-
feng ZhengUnknownGastric Cancer | Type 2 DiabetesChina
-
Daping Hospital and the Research Institute of Surgery...RecruitingSmall Intestine Length MeasurementChina
-
Imperial College LondonCompletedEating BehaviorIreland
-
University Hospital, GrenobleClinical Investigation Centre for Innovative Technology Network; Pelican HealthCompleted
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Minia UniversityCompleted